Direxion Daily S&P Biotech Bear 3X ETF (LABD) Declines 1.72% for Sep 17

September 17, 2017 - By Richard Conner

Sep 17 is a negative day so far for Direxion Daily S&P Biotech Bear 3X ETF (NYSEARCA:LABD) as the ETF is active during the day after losing 1.72% to hit $5.13 per share. The exchange traded fund has net assets and 9.79% volatility this month.

Over the course of the day 902,752 shares traded hands, as compared to an average volume of 3.54M over the last 30 days for Direxion Daily S&P Biotech Bear 3X ETF (NYSEARCA:LABD).

The ETF is -85.89% of its 52-Week High and 3.54% of its low, and is currently having ATR of 2.56. This year’s performance is -52.98% while this quarter’s performance is -31.36%.

The ETF’s YTD performance is 0%, the 1 year is 0% and the 3 year is 0%.

More notable recent Direxion Daily S&P Biotech Bear 3X Shares (NYSEARCA:LABD) news were published by: Investorplace.com which released: “Direxion Daily S&P Biotech Bear 3X Shares (LABD): The Quick Guide to LABD” on May 08, 2017, also Quotes.Wsj.com with their article: “Direxion Daily S&P Biotech Bear 3X Shares” published on May 29, 2015, Realmoney.Thestreet.com published: “This Correction Could Gain Some Traction” on July 05, 2017. More interesting news about Direxion Daily S&P Biotech Bear 3X Shares (NYSEARCA:LABD) were released by: Investorplace.com and their article: “Be Careful Before Loving Leveraged Biotech ETFs” published on October 06, 2015 as well as Etfdailynews.com‘s news article titled: “Triple Leveraged Biotech Fund Sees Massive Outflows As Biotech Cools (LABU)” with publication date: September 06, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: